Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36
Eur Urol Open Sci. 2022 Nov 16:46:145-146.
doi: 10.1016/j.euros.2022.10.018.
eCollection 2022 Dec.